CoreCap Advisors’s MapLight Therapeutics MPLT Stock Holding History

CoreCap Advisors’s Portfolio MPLT Stock Details MPLT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$92	Buy	+9	New	+$169	﹤0.01%	3059

Other funds holding MPLT

Market Street Wealth Management Advisors Indianapolis, Indiana $703M AUM 10.22% 1-Year Est. Return

Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return

GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return

FFO

Fortitude Family Office Scottsdale, Arizona $586M AUM 20.58% 1-Year Est. Return

CoreCap Advisors's MPLT Position: Q3 2026 in Review

CoreCap Advisors opened a new position in MapLight Therapeutics (MPLT) in Q3 2026: 9 shares worth $92. The stake represents ﹤0.01% of the portfolio and ranks #3059 among its holdings.

5 funds tracked by Wall St. Rank hold MPLT as of Q3 2026.

CoreCap Advisors held 9 shares of MapLight Therapeutics worth $92 as of Q3 2026.
MapLight Therapeutics was a new CoreCap Advisors position in Q3 2026.
MapLight Therapeutics made up ﹤0.01% of CoreCap Advisors's portfolio in Q3 2026, its #3059 holding.
5 funds tracked by Wall St. Rank held MapLight Therapeutics as of Q3 2026.

Based on CoreCap Advisors's 13F filing for Q3 2026, filed 8 Oct 2026.